VirtUal
AnnUal Update in CardiovaSCUlar DiSeaSeS

SatUrday, november 7, 2020

Education Geared to the Entire Cardiovascular Care Team 7.0 AMA PRA Category I Credit(s)™, 7.0 ABIM Medical Knowledge MOC Points (MOC), 7.0 Contact Hours of Continuing Nursing Education (CNE), 3.0 Pharmacotherapeutic Nursing Contact Hours (CNERx) and 3.0 Contact Hours (0.300 CEUs) of the Accreditation Council for Pharmacy Education (CPE)

Featuring Speakers from Across Missouri on Topics Such as Innovation in the Practice of CV Medicine, Clinician Well-Being, Ischemic Heart Disease, Heart Failure, Pediatric Cardiology, CV Team Manager Track, Cath Lab Manager Track, Fellows in Training Oral Abstract, Competition, and Nuclear Stress Testing in 2020: A Debate

Keynote Speaker
Ami Bhatt, M.D., F.A.C.C.
Program Chair
Gabriel Soto, M.D., Ph.D., F.A.C.C., F.H.R.S.
Program Vice Chair
Anna Grodzinsky, M.D., F.A.C.C.
Jointly Provided By
The American College of Cardiology Foundation and the Missouri Chapter of the American College of Cardiology

November 7, 2020 Schedule


Pre-Conference Session

7:00 A.M. - 7:50 A.M. (Optional)

Track 1: ECG Case Reviews
Target Audience: Primary Care Providers and APRNs
Gabriel Soto, M.D., Ph.D., F.A.C.C

Track 2: ECHO Case Reviews
Target Audience: Cardiologists and FITs.
Sridevi Reddy Pitta, M.D., F.A.C.C.

Opening General Session

8:00 A.M. - 9:45 A.M.

Welcome

  • Gabriel Soto, M.D., F.A.C.C. Program Chair
  • Anna Grodzinsky, M.D., F.A.C.C., Program Vice Chair
  • Session Moderator: Andrew M. Kates, M.D., F.A.C.C

Keynote Address | Emerging Models in Healthcare Delivery

  • Ami Bhatt, M.D., F.A.C.C.

Special Focus Speaker | Clinician Well Being

  • Laxmi Mehta, M.D., F.A.C.C.

ACC Overview | Diversity and Inclusion Initiatives

  • Athena Poppas, M.D., F.A.C.C.

Missouri ACC Update

  • Michael L. Main, M.D., F.A.C.C.
9:45 A.M.-10:00 A.M.

Break & Exhibitor Networking

Specialty Session 1: 10:00 A.M.- 11:30 A.M.

Track 1: FIT Oral Abstract Competition

Moderator:

Michael L. Main, M.D., F.A.C.C

  • Featuring the Top Six Rated Oral Abstracts Selected.
  • Format: Seven Minute Presention followed by Five Minutes of Q&A.
  • All other abstracts will be available for review after the meeting.

Track 2: APRN Team Members

Moderator:

Margaret Capriglione, A.P.R.N., A.N.P.-B.C.

Glycemic Control | Janet Stewart, M.S.N., A.P.R.N., F.N.P.-B.C., C.D.E.

When is a Troponin Not a Troponin | Bryan Beck, M.D., F.A.C.C.

Pre-Recorded Sessions:

  • Frailty And Prehabilitation: Achieving Best Surgical Outcomes | Paul Robison, M.D., F.A.C.C.
  • Life’s Simple Seven: A Place for Health Promotion In Patient Care | Parker Kohlfeld, M.D.
  • Getting To The Heart Of Youth Sports Physicals | Eric Martin, D.O.
  • Palliative Care Versus Hospice: What Is The Difference | Gina Frazier, A.P.R.N.

Track 3: Cath Lab Team Members

Moderator:

Lucas Shrum, B.S., R.C.I.S. Lauren Pulley, R.N.

Structure of Staffing

  • Roles and Responsibilities
  • Configuration of Teams
  • Scope of Practice

Clinical Orientation

  • Use of Designated Clinical Educators
  • Formal Textbook Education vs. Technical Aspects
  • Structure of Progression Competencies

Career Development

  • Opportunities Within the Laboratory
  • Opportunities Outside the Laboratory
  • Transition from the Laboratory to Industry
11:30 A.M.-11:45 A.M.

Break & Exhibitor Networking

Debate Session

11:45 A.M.-12:45 P.M

Nuclear Stress Testing in 2020: A Proven Diagnostic Tool for the Modern Era or an Antiquated Relic?

John Spertus, M.D., F.A.C.C. and Robert Gropler, M.D., F.A.C.C.

12:45 P.M.-1:00 P.M

Break & Exhibitor Networking

Specialty Session 2: 1:00 P.M.-2:30 P.M.

Track 1: Ischemic Heart Disease

Moderator:

Toniya Singh, M.D., F.A.C.C

  • Case presentation (IHD) - Krishna Patel, M.D.
  • PCI Indications for Stable CAD - John Saxon, M.D., F.A.C.C.
  • Duration of DAPT Post-PCI - Sri Pitta, M.D., F.A.C.C.
  • Management of Stable IHD in Absence of Intervention - Dominique Williams, M.D
  • Role of Non-invasive Imaging for Stable IHD - Tim Bateman, M.D., F.A.C.C.

Roundtable Discussion

Track 2: Heart Failure

Moderator:

Justin Vader, M.D., F.A.C.C.

  • Case presentation (HF) - Ankit Bhatia, M.D.
  • Evolution of Acute HF Rx - Anastasia Armbruser, Pharm.D., B.C.P.S.
  • Evolution of Chronic HF Rx - Michael Nassif, M.D., F.A.C.C.
  • Evolution of Device-Based HF Rx - Gil Vardi, M.D., F.A.C.C.

Roundtable Discussion

Track 3: Pediatric Cardiology

Moderator:

Aarti Dalal, D.O., F.A.C.C.

Management of Single Ventricle/ High Risk Pediatric Patients in the Age of Telemedicine and Technology

Current Single Ventricle Data: Introduction | Jamie Colombo, D.O. Management Panel: How To Do It Right:
CHAMP Program | Lori Erickson, Ph.D. Locus Program | Mayte Figueroa, M.D., Blaire Kulp, N.P. SLU Program | Gloria Lehmann, M.D.

Exercise and Pediatric Patients: Using Exercise Data to Optimize Care in Congenital Heart Disease

Building a Pediatric Centric EST Lab | William Orr, M.D., F.A.C.C. Introduction to Exercise/CPET | Mustafa Husaini, M.D. Interpreting EST in CHD -> How it Should Influence your Practice | David White, Ph.D. Pediatric Cardiovascular Manifestations, Updates on the Missouri COVID Response William Orr, M.D., F.A.C.C

Pre-Recorded Sessions:

  • Updates on Pediatric Aortopathies | Glen Iannucci, M.D.
  • Management of VUS Mutations in Pediatric Cardiology Patients | Andrew Landstrom, M.D.
  • Update on Pediatric Preventative Cardiology | Sarah Studyvin, M.D.
  • Updates on Use of VADs in Pediatric Patients | Marion Ybarra, M.D.
  • Updates on Hypertrophic Cardiomyopathy | Deepa Mokshagundam, M.D.
2:30 P.M. - 2:45 P.M.

Closing Remarks

3:00 P.M.-4:00 P.M.

Women in Cardiology Section Meeting

Moderator:

Sridevi Pitta, M.D., F.A.C.C.

Anna Grodzinsky, M.D., F.A.C.C.

Learning Objectives

  • Identify and discuss current pharmacologic treatments and devices used in the management of congestive heart failure.
  • Discuss health promotion, risk factor modification, wellness strategies and end of life care in the cardiovascular patient
  • Identify and discuss pharmacologic and interventional strategies in the treatment of atherosclerotic heart disease
  • Discuss factors in selecting and using medications effectively in cardiovascular patients.

Thank You To Our Hospital Sponsors